All In MedTech

Device Trial Radar · NCT06365606

Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis Syphilis Ab Test at the Point- Of-Care Sites

A Prospective Cross-Sectional Study to Evaluate Diagnostic Sensitivity and Specificity of iStatis Syphilis Ab Test at the Point- Of-Care Sites

Last checked: Nov 20, 2026Latest source record: Aug 12, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

1,500

Actual

Start

Mar 14, 2024

Primary completion

May 13, 2024

Study completion Jul 11, 2024

Sponsor

Lead sponsor
bioLytical LaboratoriesNot on our public-company list
Sponsor type
Industry
First posted
Apr 15, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
Double (participant, care provider)
Primary purpose
Screening
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is a prospective cross-sectional study in which surgically non-invasive sample- taking is done only for the purpose of the study. Capillary (fingerstick) whole blood and plasma (i.e., obtained through venous EDTA whole blood collection and processing) are collected by a healthcare professional. The collected samples are tested in a routine testing environment, i.e., healthcare providers at

Conditions

  • Syphilis Infection
  • Syphilis

Interventions

  • iStatis Syphilis Ab TestDevice

    Capillary (fingerstick) blood, venous whole blood and plasma samples prospectively collected from the participants will be tested on the iStatis Syphilis Ab Test.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sensitivity and specificity of the iStatis Syphilis Ab TestTime frame: 15 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Epicentre Health Research

    Hillcrest, KwaZulu-Natal, South Africa

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.